BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 20697746)

  • 1. Radiotherapy-induced nausea and vomiting (RINV): MASCC/ESMO guideline for antiemetics in radiotherapy: update 2009.
    Feyer PC; Maranzano E; Molassiotis A; Roila F; Clark-Snow RA; Jordan K;
    Support Care Cancer; 2011 Mar; 19 Suppl 1():S5-14. PubMed ID: 20697746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiotherapy-induced nausea and vomiting (RINV): antiemetic guidelines.
    Feyer PCh; Maranzano E; Molassiotis A; Clark-Snow RA; Roila F; Warr D; Olver I
    Support Care Cancer; 2005 Feb; 13(2):122-8. PubMed ID: 15592688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation induced nausea and vomiting.
    Feyer P; Jahn F; Jordan K
    Eur J Pharmacol; 2014 Jan; 722():165-71. PubMed ID: 24157983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic Management of Radiation-Induced Nausea and Vomiting.
    Feyer P; Jahn F; Jordan K
    Biomed Res Int; 2015; 2015():893013. PubMed ID: 26425557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation-induced nausea and vomiting: a comparison between MASCC/ESMO, ASCO, and NCCN antiemetic guidelines.
    McKenzie E; Zaki P; Raman S; Olson R; McFarlane T; DeAngelis C; Chan S; Pidduck W; Razvi Y; Bushehri A; Chow E
    Support Care Cancer; 2019 Mar; 27(3):783-791. PubMed ID: 30607675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2016 updated MASCC/ESMO consensus recommendations: prevention of radiotherapy-induced nausea and vomiting.
    Ruhlmann CH; Jahn F; Jordan K; Dennis K; Maranzano E; Molassiotis A; Roila F; Feyer P
    Support Care Cancer; 2017 Jan; 25(1):309-316. PubMed ID: 27624464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of antiemetic studies for radiation-induced nausea and vomiting within an outpatient palliative radiotherapy clinic.
    McKenzie E; Chan D; Parsafar S; Razvi Y; McFarlane T; Rico V; Pasetka M; DeAngelis C; Chow E
    Support Care Cancer; 2019 Sep; 27(9):3245-3252. PubMed ID: 31119459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2023 Updated MASCC/ESMO Consensus Recommendations: prevention of radiotherapy- and chemoradiotherapy-induced nausea and vomiting.
    Ruhlmann CH; Jordan K; Jahn F; Maranzano E; Molassiotis A; Dennis K
    Support Care Cancer; 2023 Dec; 32(1):26. PubMed ID: 38097904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiemetics in children receiving chemotherapy. MASCC/ESMO guideline update 2009.
    Jordan K; Roila F; Molassiotis A; Maranzano E; Clark-Snow RA; Feyer P;
    Support Care Cancer; 2011 Mar; 19 Suppl 1():S37-42. PubMed ID: 20824481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granisetron in the control of radiotherapy-induced nausea and vomiting: a comparison with other antiemetic therapies.
    Feyer P; Seegenschmiedt MH; Steingraeber M
    Support Care Cancer; 2005 Sep; 13(9):671-8. PubMed ID: 16044252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practice Patterns for Prevention of Chemotherapy-Induced Nausea and Vomiting and Antiemetic Guideline Adherence Based on Real-World Prescribing Data.
    Aapro M; Scotté F; Escobar Y; Celio L; Berman R; Franceschetti A; Bell D; Jordan K
    Oncologist; 2021 Jun; 26(6):e1073-e1082. PubMed ID: 33555084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International patterns of practice in the management of radiation therapy-induced nausea and vomiting.
    Dennis K; Zhang L; Lutz S; van Baardwijk A; van der Linden Y; Holt T; Arnalot PF; Lagrange JL; Maranzano E; Liu R; Wong KH; Wong LC; Vassiliou V; Corn BW; De Angelis C; Holden L; Wong CS; Chow E
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):e49-60. PubMed ID: 22704982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment implications for radiation-induced nausea and vomiting in specific patient groups.
    Horiot JC; Aapro M
    Eur J Cancer; 2004 May; 40(7):979-87. PubMed ID: 15093572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2016 Updated MASCC/ESMO Consensus Recommendations: Controlling nausea and vomiting with chemotherapy of low or minimal emetic potential.
    Olver I; Ruhlmann CH; Jahn F; Schwartzberg L; Rapoport B; Rittenberg CN; Clark-Snow R
    Support Care Cancer; 2017 Jan; 25(1):297-301. PubMed ID: 27572335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2023 updated MASCC/ESMO Consensus recommendations: Prevention of nausea and vomiting following moderately emetic risk antineoplastic agents.
    Scotté F; Schwartzberg L; Iihara H; Aapro M; Gralla R; Hesketh PJ; Jordan K; Chow R; Herrstedt J
    Support Care Cancer; 2023 Dec; 32(1):45. PubMed ID: 38114821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity--state of the art.
    Grunberg SM; Warr D; Gralla RJ; Rapoport BL; Hesketh PJ; Jordan K; Espersen BT
    Support Care Cancer; 2011 Mar; 19 Suppl 1():S43-7. PubMed ID: 20972805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multidisciplinary expert opinion on CINV and RINV, unmet needs and practical real-life approaches.
    Bossi P; Airoldi M; Aloe Spiriti MA; Antonuzzo A; Bonciarelli G; Campagna A; Cassano A; Murialdo R; Musio D; Silvano G
    Expert Opin Drug Saf; 2020 Feb; 19(2):187-204. PubMed ID: 32005072
    [No Abstract]   [Full Text] [Related]  

  • 18. Nausea and vomiting induced by gastrointestinal radiation therapy: current status and future directions.
    Dennis K; Poon M; Chow E
    Curr Opin Support Palliat Care; 2015 Jun; 9(2):182-8. PubMed ID: 25872120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact and management of chemotherapy/radiotherapy-induced nausea and vomiting and the perceptual gap between oncologists/oncology nurses and patients: a cross-sectional multinational survey.
    Vidall C; Fernández-Ortega P; Cortinovis D; Jahn P; Amlani B; Scotté F
    Support Care Cancer; 2015 Nov; 23(11):3297-305. PubMed ID: 25953380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines for the control of nausea and vomiting with chemotherapy of low or minimal emetic potential.
    Olver I; Clark-Snow RA; Ballatori E; Espersen BT; Bria E; Jordan K
    Support Care Cancer; 2011 Mar; 19 Suppl 1():S33-6. PubMed ID: 20803222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.